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Abstract 
Although there is considerable literature pertaining to IgE and non IgE-mediated food allergy, there is a paucity of 
information on non-immune mediated reactions to foods, other than metabolic disorders such as lactose intolerance. 
Food additives and naturally occurring ‘food chemicals’ have long been reported as having the potential to provoke 
symptoms in those who are more sensitive to their effects. Diets low in ‘food chemicals’ gained prominence in the 
1970s and 1980s, and their popularity remains, although the evidence of their efficacy is very limited. This review 
focuses on the available evidence for the role and likely adverse effects of both added and natural ‘food chemicals’ 
including benzoate, sulphite, monosodium glutamate, vaso-active or biogenic amines and salicylate. Studies assess-
ing the efficacy of the restriction of these substances in the diet have mainly been undertaken in adults, but the paper 
will also touch on the use of such diets in children. The difficulty of reviewing the available evidence is that few of 
the studies have been controlled and, for many, considerable time has elapsed since their publication. Meanwhile 
dietary patterns and habits have changed hugely in the interim, so the conclusions may not be relevant for our cur-
rent dietary norms. The conclusion of the review is that there may be some benefit in the removal of an additive or a 
group of foods high in natural food chemicals from the diet for a limited period for certain individuals, providing the 
diagnostic pathway is followed and the foods are reintroduced back into the diet to assess for the efficacy of removal. 
However diets involving the removal of multiple additives and food chemicals have the very great potential to lead 
to nutritional deficiency especially in the paediatric population. Any dietary intervention, whether for the purposes of 
diagnosis or management of food allergy or food intolerance, should be adapted to the individual’s dietary habits and 
a suitably trained dietitian should ensure nutritional needs are met. Ultimately a healthy diet should be the aim for all 
patients presenting in the allergy clinic.
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Background
The recent food allergy guidelines from the European 
Academy of Allergy and Clinical Immunology give clear 
advice on how to diagnose an immune-mediated food 
allergy [1]. However, non-immune mediated reactions 
to foods are not addressed. Food additives and natu-
rally occurring ‘food chemicals’ are attributed by many 
patients as the cause of their symptoms. Studies have 
assessed the potential for food additives and food chemi-
cals to cause adverse symptoms, but robust research is 
difficult to conduct due to a number of factors: perform-
ing double blind placebo controlled challenges using 
foods or varying dosages of individual additives, setting 
inclusion criteria, standardizing the outcome and ruling 
out potential co- factors. Also the mechanisms involved 
have been poorly studied; although some preliminary 
data indicates the possible role of IgE involvement, many 
other mechanisms have also been proposed [2].
A vast range of adverse reactions have been attributed 
to the consumption of these added or natural ‘food chem-
icals’. The most frequent clinical features are chronic urti-
caria or angioedema [3], but symptoms can also include 
atopic eczema, [4] flushing, hypotension, abdominal 
pain, diarrhoea and asthmatic reactions, and occasionally 
severe or anaphylactoid or severe (anaphylactic) reactions 
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[5, 6]. Due to the difficulty in diagnosing these condi-
tions, the true prevalence of adverse reactions caused 
by food chemicals is unknown. A recent cross-sectional 
study from Japan estimated that the prevalence of chemi-
cal intolerances was 7.5 %, with fatigue, depressed mood 
and somatic symptoms positively correlated with a diag-
nosis of the condition [7]. Some groups appear to be at 
higher risk for example steroid-dependent asthmatics, 
those with marked airway hyper-responsiveness, and 
those with chronic asthma appear to be at greater risk 
of sulphite sensitivity [6]. Such prevalence data is even 
harder to come by in the paediatric population, where 
adverse reactions to food chemicals are poorly studied.
The range of the additives and natural substances 
potentially involved in non-immune mediated reactions 
in both children and adults makes it very difficult to 
undertake a systematic review of the literature. The fol-
lowing review provides an overview of the prevalence and 
foods thought to be involved in sensitivity to food addi-
tives, vaso-active amines and salicylates adults. It also 
considers separately the evidence for the dietary exclu-
sion of these substances in the paediatric population.
Food additives
Sulphites
Sulphur dioxide has long been regarded as an air pol-
lutant, but sensitivity to sulphites in foods was first 
described in 1973 (Kochen). Sulphites, readily metabo-
lised to sulphate (SO4) by sulphite oxidase [8] mainly 
occur in the human diet due to the addition of sodium/
potassium sulphite/metabisulphite to foods to prevent 
enzymatic and non-enzymatic browning, control oxida-
tion and prevent bacterial growth. Sulphites added to 
foods will be present either as a free form mix of sul-
phur dioxide, bisulphite and sulphite, or bound to car-
bohydrates or proteins [9]. A plethora of reports in the 
1980s demonstrated that sulphites in foods were provok-
ing adverse reactions; by 1984 the US Food and Drug 
Administration had received more than 250 reports of 
suspected sulphite reactions including six deaths [10]. 
Thus both the European Union and the US Food and 
Drug Administration have regulated the use of sulphites, 
requiring foods containing more than 10 ppm (10 mg/kg) 
to be labelled, but there is significant variation between 
levels for the same foods [11–15]. Foods containing a 
high level of free form sulphite are more likely to pro-
voke a reaction and this dictates how much sulphite can 
be added [16]. Foods usually containing significant levels 
of added sulphite include cider, white wine, and dried 
fruits—see Table 1 [5, 17, 118].
Sensitivity to sulphites mainly affects patients with 
asthma, especially those with severe steroid-dependant 
asthma. Bush and colleagues undertook single-blind 
challenges with encapsulated sodium metabisulphite 
in 203 asthmatic subjects and reported a prevalence of 
3.9 % in asthmatic patients, with those who were steroid 
dependant being most at risk [18]. Buckley et  al., using 
similar methodology, found a similar prevalence of 4.6 % 
in a large cohort of asthmatic patients [19]. A recent 
review by Vally and Misso suggested that 3–10 % of asth-
matics experience symptoms on exposure to ingested 
sulphites [5]. An analysis of sulphite-sensitive cases in 
Korea found that two phenotypes of sulphite sensitiv-
ity existed, those with sulphite sensitive asthma was the 
most common, affecting two-thirds of their cohort, with 
the remainder having sulphite-sensitive urticaria [20]. 
Sulphites can cause urticaria and angio-oedema both 
through topical application of sulphite containing cos-
metics or skin reactions following oral ingestion of sul-
phite [5]. Other reactions are less common but include 
anaphylaxis [6] and rhinitis [21].
It is postulated that the inhalation of sulphur dioxide, 
generated from ingested sulphites may cause respiratory 
symptoms [6, 22]. Other mechanisms suggested include 
IgE-mediated reactions [6, 23, 24], a deficiency of sul-
phite oxidase [25], and a role for leukotrienes [26]. Due 
to the unpredictability of the level of available sulphite in 
different foods, and because sulphite sensitive individu-
als will not all respond in the same way to sulphite-con-
taining foods, few trials have used foods when evaluating 
sulphite sensitivity [27]. Taylor and colleagues undertook 
double-blind, placebo-controlled food challenges (DBP-
CFC) with foods known to be high in sulphites (lettuce, 
dehydrated potato, shrimp, dried apricots, white grape 
juice) in eight subjects whose sulphite sensitivity was 
established through the use of DBPCFC with encapsu-
lated potassium metabisulphite [28]. Four patients failed 
to respond to any of the challenges, four responded 
to sulphited lettuce and there was a varying degree of 
response to the other foods. Using DBPCFC Vally and 
Thompson found only 16 % of wine sensitive asthmatics 
responded to sulphite additives in wine [29].
Benzoates
Benzoic acid is produced by many plants and has also 
been detected in animals, so is present in many foods, 
including berries and milk products, usually in relatively 
low concentrations of up to 40  mg/kg [30–32]. Benzo-
ate can also be a product of digestion, e.g. cinnamic acid 
from cinnamon is oxidised to a benzoate salt in the liver 
[33]. Benzoates are also added in much higher concentra-
tions to soft drinks, jams, sweets, chocolates, ice creams, 
pickles, baked goods due to their antimicrobial proper-
ties—see Table 1 [34, 35].
Benzoates have been linked to chronic urticaria, 
asthma, atopic dermatitis, rhinitis and anaphylaxis 
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although there is limited good quality evidence to sup-
port these findings. Wuthrich et al. proposed that benzo-
ates may be involved via a type IV sensitisation causing 
allergic contact dermatitis [36] and Van Bever et al. used 
DBPCFC to show that benzoates may cause atopic der-
matitis [37]. Worm et  al. also undertook DBPCFC to 
show a late phase response in atopic dermatitis, but the 
capsules used contained a mixture of additives includ-
ing benzoates rather than benzoates alone [38]. In a more 
recent study using a DBPCFC to a mixture of food addi-
tives including benzoates, Park et al. showed they had no 
effect on atopic dermatitis [39].
In another study, Weber et  al. hypothesised that ben-
zoates could exacerbate asthma, however in the DBPCFC 
study, only 1/43 subjects had a positive result, with indi-
vidual testing negative on re-challenge 2 years later [40]. 
In 1981 Tarlo et al. found only 1/28 subjects with chronic 
asthma reacted to benzoates, but did not respond symp-
tomatically to a benzoate-free diet [41]. Persistent rhi-
nitis has also been linked to consumption of benzoates; 
Pacor et al. showed that 8.8 % (20 subjects) reacted to a 
DBPCFC challenge to monosodium benzoate. The sub-
jects with a positive challenge had previously reported an 
improvement in symptoms within in 1 month of using an 
additive free diet and a return in rhinitis symptoms with 
the adoption of a food additive rich diet [42].
Only two robust studies have assessed the link between 
chronic urticaria and benzoates using blinded placebo 
controlled trials. Ortolani et al. reported that 3/72 (4 %) 
patients reacted to benzoates [43], but Simon et al. found 
no positive reactions in their study [44]. Several studies 
using dietary elimination in chronic urticaria showed 
positive outcomes to benzoates, but they had either no 
clear outcome measures, lack of blinding and/or no pla-
cebo [45–47]. Rajan and colleagues showed that although 
2/100 patients had a positive response to single-blinded 
challenges with the individual additives including sodium 
benzoate, neither responded to DBPCFC [48]. They con-
cluded that food and drug additives were a rare cause of 
chronic urticaria and that avoidance should not be rec-
ommended. It is unclear why these studies offer contra-
dictory evidence and also whether natural benzoate is 
also likely to provoke adverse reactions in the same way 
that added benzoate might.
Monosodium glutamate
Monosodium glutamate (MSG—E621) is a common 
added ingredient to savoury foods. Glutamate also occurs 
naturally in other foods, with ripening of fruits such as 
tomatoes and the curing of meat such as ham, being 
associated with an increase in the free amino acids such 
as glutamate [49]—see Table 1. The l-glutamate derived 
from dried kelp or seaweed, was originally used to make 
MSG prior to synthetic derivatives being developed [50]. 
Originally described as ‘Chinese Restaurant Syndrome’ 
in 1968 [51], results from studies utilising DBPCFC have 
suggested some individuals could experience symptoms 
from the ingestion of MSG, although only in quantities 
greater than the normal dietary intake [50, 52]. Other 
studies have found MSG does not provoke any symp-
toms [53]. Geha et al. conducted a DBPC crossover study 
on 130 subjects with reported MSG sensitivity; 2/130 
responded to a large dose given without food, with no 
responses noted when MSG was given with food [54]. 
Although the glutamate in MSG is chemically indis-
tinguishable from glutamate present in food proteins 
and is metabolized in the same way [55], it is currently 
unknown whether foods high in natural bound or free 
form glutamate can cause the same symptoms as MSG.
This additive has been linked to asthma, headache, 
urticaria and angioedema, rhinitis, psychiatric disor-
ders and convulsions [56, 57]. A link with asthma was 
first noted by Allen and Baker [58] although subsequent 
studies have shown mixed outcomes. Schwartzstein et al. 
reported that DBPC with MSG were negative in 12 sub-
jects with asthma [59]. Similarly, Woods et  al. reported 
no changes in forced expired volume in one second 
(FEV1) values and no immediate or late asthmatic reac-
tions in their cohort of 12 subjects [60]. Germano et al. 
found 1/30 participants experienced a significant reduc-
tion in FEV1 during single blind provocation, but this 
was not reproducible during DBPC challenges [61].
Persistent rhinitis linked to MSG has been demon-
strated in DBPC challenges by Asero, but only in a hand-
ful of subjects [62]. Pacor et  al. found 8/226 non-atopic 
subjects exhibiting subjective symptoms of rhinitis after 
a DBPC MSG challenge, and concluded that reactions 
to additives could precipitate rhinitis in some patients 
[42]. Case reports have linked MSG to urticaria [21], but 
Simon et  al. showed only 2/65 subjects had a positive 
response in single blinded challenge, neither of whom 
were positive to a DBPC challenge [44].
Headache has been the most commonly reported 
symptom in relation to MSG [63] Yang et al. undertook 
DBPCFC in 61 subjects with self-reported sensitivity 
to MSG; 18/61 had no response, 21/61 had a placebo 
response and 22/61 a positive response to the active 
challenge only. On re-challenge a threshold dose of 2.5 g 
MSG was established [64]. Baad-Hansen et al. conducted 
a DBPCFC in 14 healthy individuals and reported a sig-
nificant increase in reported headache and pericranial 
muscle tenderness after taking an individually tailored 
dose of MSG (150  mg/kg) [65]. However, despite these 
studies, an authoritative view is that the weight of the 
literature does not presently support the use of an MSG 
free diet for patients with chronic headaches [50].
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Naturally occurring ‘food chemicals’
Biogenic/vasoactive amines
Biogenic or vasoactive amines are produced by bacteria 
during fermentation, storage or decay [6, 66–68]. They 
include beta-phenylethylamine, tyramine, tryptamine, 
putrescine, cadaverine, spermine and spermidine, but 
histamine is the one most frequently linked to food-
related symptoms. When plasma histamine levels are 
raised above the normal range (0.3–1.0 ng/mL) this pro-
duces certain effects. For example a level of 1–2 ng/mL 
causes increased gastric acid secretion and heart rate, 
with, flushing, headache, urticaria, pruritus and tachycar-
dia occurring at a level of 3–5 ng/mL), bronchospasm at 
a level of 7–12 ng/mL and cardiac arrest occurring at lev-
els of 100 ng/mL [6]. Thus large amounts of ingested his-
tamine can cause significant symptoms in otherwise well 
individuals. For example symptoms of flushing, sweat-
ing, urticaria, GI symptoms, palpitations and in severe 
cases bronchospasm may occur following the consump-
tion of spoiled fish [69]. This condition, known as scom-
broid poisoning, occurs due to the high level of histidine 
in certain fish species being converted into histamine by 
marine bacteria [70]. Due to the nature of the symptoms 
caused, reactions involving vasoactive amines may there-
fore be incorrectly diagnosed as a food allergy.
Although 75 mg of liquid histamine can provoke symp-
toms in healthy volunteers [71], defining a safe thresh-
old level for sensitive individuals is difficult [72]. Foods 
generally considered to contain high levels of vaso-active 
amines are shown in Table  2, however the amounts of 
histamine found in different foods varies according to 
the type of bacteria, food composition and conditions for 
fermentation [73]. Bodmer et al. found that mean levels 
of histamine were 3.63 mg/L for French wines, 2.19 mg/L 
for Italian wines and 5.02  mg/L for Spanish wines [68]. 
Symptoms to wine may not always be a reliable indica-
tor of sensitivity to histamine. In a placebo-controlled 
study, Kanny et  al. found no correlation between wine 
histamine content and wine intolerance, and concluded 
that other vaso-active amines or sulphites may be more 
relevant in intolerance to wine [74]. It has been proposed 
that other foods may be able to cause histamine release 
directly from tissue mast cells [6] although evidence for 
this is lacking [75].
Wantke et  al. found a diet low in vasoactive amines 
alleviated chronic headache in 73  % of patients [76]. 
Another study reported that 27/44 (61 %) of subjects had 
a significant improvement in idiopathic urticaria, angio-
oedema and pruritus on a diet low in dietary amines, 
although foods containing additives or high in natural 
salicylate were also restricted [72]. King and colleagues 
reported subjects with chronic urticaria/angioedema 
had a marginally significant reduction in their use of 
antihistamines on a histamine-reducing diet compared to 
a control group who eliminated artificial sweeteners from 
their diet. However response to the diet varied and the 
numbers in each group were very low [77]. Another study 
found that 58 % of adult patients with irritable bowel syn-
drome (IBS) considered foods rich in vasoactive amines, 
such as wine, beer, salami and cheese, to be a cause of 
their symptoms [78].
The diagnosis of sensitivity to vasoactive amines is usu-
ally made through history and dietary exclusion; how-
ever some studies have suggested that the measurement 
of diamine oxidase (DAO) levels may be helpful. One 
study found a DAO level <3 kU/mL was associated with 
reported symptoms to high histamine foods, whereas a 
level of >10 kU/mL indicated histamine intolerance was 
unlikely [6]. Patients with chronic idiopathic urticaria 
and GI symptoms have been shown to have reduced 
DAO activity [79, 80]. Another study reported that the 
size of the skin prick test wheal to histamine after 50 min, 
the ‘histamine 50-skin-prick test’, was a useful diagnos-
tic indicator; 82 % of subjects with histamine intolerance 
maintained a wheal size greater than 3  mm compared 
with 18 % of controls [81].
Salicylates
Salicylate intolerance has been defined as ‘a nonspe-
cific antigen-induced pseudo-allergic hypersensitivity 
reaction to salicylic acid, its derivatives or other related 
organic or inorganic acids of similar chemical structure’ 
[82]. Salicylic acid is widely distributed in plant foods 
and, like its synthetic counterpart acetyl salicylate (Aspi-
rin™) has anti-inflammatory activity. Acetyl salicylate is 
a potent inhibitor of COX-1, an isoform of the enzyme 
cyclooxygenase (COX), which prevents the conversion of 
arachidonic acid to cyclic prostanoids, whereas salicylic 
acid inhibits COX-2 gene expression [83, 84]. A diet rich 
in spices, which contain high levels of in salicylic acid, 
has been linked to lower levels of colorectal cancer in 
rural inhabitants of Southern India [85], although caution 
has been advised with regard to an over-emphasis on the 
importance of dietary salicylates compared with other 
bioactive plant phenolics in the diet [86].
The reported level of salicylates in different foods is 
highly variable between studies. Swain et  al. published 
the salicylate content of 333 foods [87] and these data 
continue to underpin dietary salicylate avoidance advice. 
Subsequent studies have reported different results for 
the same foods [88–90], possibly due to diverse analyti-
cal methods and the origin, processing and storage of the 
foods tested [91–93]. Table  2 gives a list of high salicy-
late foods based on all of the published data. There is 
also uncertainty regarding the bioavailability of dietary 
salicylate; Jansen et  al. reported that urinary salicylate 
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excretion showed that the bioavailability of dietary salic-
ylate in most people is low [94], whereas Lawrence and 
colleagues showed bioavailability to be high [95]. Curry 
spices, universally agreed as being high in natural salicy-
late, not only have a high bioavailability, they also inhibit 
both COX-1 and COX-2, which may indicate they could 
be a more important dietary factor than other high salic-
ylate foods [85].
Baenkler has proposed that 2.5  % of Europeans may 
have salicylate sensitivity [96], but the evidence on 
which this assertion is based is sparse. Aspirin exac-
erbated respiratory disease (AERD), an inflammatory 
disease exacerbated by aspirin or other non-steroidal 
anti-inflammatory drugs (NSAIDS), usually presents in 
adult life, and affects up to 20 % of asthmatic subjects and 
40 % of those with nasal polyps [97]. It has been shown 
that AERD subjects have down regulation of COX-2 
expression in nasal polyps [98], so it could be hypoth-
esised that such individuals might be more likely to be 
affected by dietary salicylate but there is conflicting evi-
dence. Corder and Buckley reported that a challenge with 
salicylic acid had a significant effect on the lung function, 
whereas Dahlen et al. found no such reactions [99, 100].
Salicylate intolerance has also been proposed as a cause 
of other conditions; Raithel et  al. proposed that 2–7  % 
of all patients with inflammatory bowel syndrome and 
food allergies could be affected by salicylate intolerance 
[82]. Gibson and Barrett suggest that since there are no 
published studies demonstrating efficacy of salicylate 
avoidance in gut disease, they recommend the dietary 
restriction of fermentable oligosaccharides, disaccha-
rides, monosaccharides and polyols (FODMAPs™) as 
first line therapy for the majority of patients with func-
tional bowel symptoms [101, 102].
Chemical diets in children
Evidence for the efficacy of diets free from individual 
additives or high levels of natural food chemicals in 
children is sparse. There is a lack of convincing pub-
lished data on the effect of the avoidance of food addi-
tives, although Supramaniam et  al. demonstrated that 
3/36 (10  %) children exhibited urticaria or angioedema 
in response to MSG [103], and avoidance of MSG was 
helpful in the management of 86  % of children aged 
2–16  years with cyclical vomiting syndrome (a vari-
ant of migraine in children) [104]. A study on benzoates 
reported that 3/25 children reacted to sodium benzoate, 
but the reaction criteria were unclear and no reactions 
occurred during placebo challenges [37]. More rigorous 
studies concluded sodium benzoate or artificial colours 
(or both) in the diet may result in increased hyperactivity 
in young children [105], although genetic variants associ-
ated with the breakdown and clearance of histamine were 
found to moderate the impact of additives on behaviour 
[106].
Studies on sulphite intolerance in asthmatic chil-
dren also appear to demonstrate some degree of effect. 
Sanz et  al. [107] found that 4/20 children with asthma 
(7–14  years of age) had a positive reaction on double-
blind challenge to sodium metabisulphite solution. How-
ever, in a subsequent study performed on 5 children with 
challenge confirmed sulphite intolerance; with a dose of 
1.5  mg of oral cyanocobalamin followed by a repeated 
sodium metabisulphite challenge only resulted in bron-
chospasm in 1/5 of the children. [108]. There is also lim-
ited evidence for the efficacy of diets low in natural food 
chemicals. In 2013, Hoffmann et  al. [109] reported that 
14/394 children who presented with gastrointestinal dis-
comfort, had both low levels of DAO and subsequently 
improved on a diet excluding foods high in histamine. 
However, the improvement was subjective, being based 
on a non-validated questionnaire and the dietary exclu-
sion was not blinded. Another study has also shown that 
a low histamine or histamine-free diet improves symp-
toms in children with DAO levels <10 kU/mL, but only 
subjective symptoms were noted [110]. An extensive 
literature review yielded no prospective randomised 
controlled studies establishing the link between hyper-
sensitivity reactions in children and salicylates.
Despite this lack of evidence, there has been a rise in 
the use of low chemical diets for children for a variety of 
conditions, in particular for atopic dermatitis, gastroin-
testinal symptoms and hyperactivity [111]. These diets 
typically remove foods high in salicylates, histamine, sul-
phites and MSG from the diet and may be used in con-
junction with the dietary elimination of milk, soy, egg and 
wheat. A retrospective case review by Gray et  al. found 
that almost half of a group of 74 children placed on a diet 
that eliminated foods naturally high in salicylates suf-
fered adverse outcomes, including nutritional deficien-
cies, food aversion and eating disorders [112]. Growth 
velocity is highest within the first years of life and a fail-
ure to achieve this potential has a far reaching impact 
on development and later health [113, 114]. Many of the 
foods that contain both additives and naturally occurring 
food chemicals which are listed in Tables  1 and 2, con-
tribute essential nutrients for growth and development. 
In addition, a lack of taste exposure during early infancy 
has been shown to lead to feeding difficulties in later 
life [115]. Therefore unwarranted dietary eliminations 
of these chemicals should be avoided in young children 
unless there is exceptional evidence as to their efficacy.
Conclusion
The lack of well-designed placebo-controlled studies 
investigating the role of many of these substances makes 
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it impossible to provide evidence-based advice for the 
efficacy of the removal of food additives, histamine and 
salicylates from the diet. No convincing data exists on 
the impact of food chemicals on atopic disorders in chil-
dren, and in light of the importance of growth and devel-
opment, these diets should be approached with caution 
in the paediatric population. For adults, the nutritional 
aspects might appear to be less of an issue, but significant 
dietary restrictions can affect nutritional status at any age 
[116]. Thus, the risk–benefit ratio should be considered 
when contemplating the dietary exclusion of multiple 
foods, particularly those foods which may confer some 
health benefit such as foods high in natural salicylates. 
The literature suggests that the removal of high histamine 
foods or those containing high levels of sulphites may 
provide some symptom relief. There is far less evidence 
on the beneficial effect of restricting other additives in 
the diet and no published evidence at all for the efficacy 
of low salicylate diets.
Studies which utilise DBPCFC have rarely shown food 
additives to be the cause of pseudoallergic symptoms. 
However, although DBPCFC with the individual addi-
tives or pure forms of histamine are ideal, they do not 
provide a ‘real-life’ scenario, where the additive or natu-
ral food chemical will be consumed as part of the food 
or food matrix. Ideally the potential cause and effect of 
foods should be reviewed on an individual basis and any 
diagnostic diet tailored to the individual, taking account 
of their symptoms and particular foods suspected, rather 
than adopting a blanket approach of a few foods diet. 
There are some foods which are a rich source of additives 
and/or natural food chemicals (Table 3) and so a limited 
removal of a few ‘high’ risk foods in adults might be a 
good first step to determine whether diet plays a role in 
symptoms.
The elimination of an additive or food chemical often 
requires a major change to the whole diet, so any ben-
efits arising from the intervention, may be due to life-
style changes incurred as a result of an improvement in 
diet, rather than to the removal of the offending addi-
tive. In addition, the placebo effects of dietary interven-
tions are as yet an unknown quantity, and require further 
study. The importance of healthy diets and diversity of 
foodstuffs has recently been demonstrated in infants 
and young children, but the lifelong effects may also be 
important in adults [117]. A healthy diet will usually con-
tain lower levels of additives and therefore a pragmatic 
approach should focus on improving the nutritional qual-
ity of the diet alongside any specific dietary exclusion is 
an important goal in all dietary interventions for non-
immune mediated reactions to foods.
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